Physician profile
Daniel Esteves
NPI 1053405993
$16,324.82
in general payments reported to CMS, 2019-2025
15 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.76 · 2021: $176 · 2022: $23.65 · 2023: $742 · 2024: $3,803 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $1,210 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,800.00 |
| Food and Beverage | $1,209.70 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14,832.87 | 2024-2025 | Bovine Collagen |
| Medtronic, INC. | $404.41 | 2021-2023 | Truclear |
| Astellas Pharma US INC | $300.30 | 2023-2024 | Veozah, Myrbetriq |
| Baxter Healthcare | $174.23 | 2023-2025 | Tisseel, Floseal, Perclot |
| Shield Therapeutics INC | $125.13 | 2023-2025 | Accrufer |
| Abbvie INC. | $112.32 | 2021-2025 | |
| Organon LLC | $88.48 | 2024-2025 | Nexplanon |
| Becton, Dickinson and Company | $67.36 | 2025 | Arista |
| Hologic Sales and Service, LLC | $56.96 | 2025 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $38.93 | 2025 | |
| Coopersurgical, INC. | $36.19 | 2023-2025 | Ally II Ups, Mara Console |
| Covidien Lp | $24.76 | 2019 | |
| Biogen, INC. | $22.74 | 2023 | Spinraza |
| Daiichi Sankyo INC. | $20.80 | 2021 | |
| Olympus America INC. | $19.34 | 2025 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Esteves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.